Percentage of surgery patients who received appropriate Venous Thromboembolism (VTE) Prophylaxis within 24 hours prior to Anesthesia Start Time to 24 hours after Anesthesia End Time.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Surgery patients who received appropriate Venous Thromboembolism (VTE) prophylaxis within 24 hours prior to Anesthesia Start Time to 24 hours after Anesthesia End Time.
Appropriate prophylaxis according to Surgery Type:
Intracranial Neurosurgery
Any of the following:
• Intermittent pneumatic compression devices (IPC) with or without graduated compression stockings (GCS)
• Low-dose unfractionated heparin (LDUH)
Low molecular weight heparin (LMWH)2
• LDUH or LMWH2 combined with IPC or GCS
General Surgery
Any of the following:
• Low-dose unfractionated heparin (LDUH)
• Low molecular weight heparin (LMWH)
• Factor Xa Inhibitor (Fondaparinux)
• LDUH or LMWH or Factor Xa Inhibitor (fondaparinux) combined with IPC or GCS
General Surgery with a reason for not administering pharmacological prophylaxis
Any of the following:
• Graduated Compression stockings (GCS)
• Intermittent pneumatic compression devices (IPC)
Gynecologic Surgery
Any of the following:
• Low-dose unfractionated heparin (LDUH)
• Low molecular weight heparin (LMWH)
• Factor Xa Inhibitor (fondaparinux)
• Intermittent pneumatic compression devices (IPC)
• LDUH or LMWH or Factor Xa Inhibitor (fondaparinux) combined with IPC or GCS
Urologic Surgery
Any of the following:
• Low-dose unfractionated heparin (LDUH)
• Low molecular weight heparin (LMWH)
• Factor Xa Inhibitor (fondaparinux)
• Intermittent pneumatic compression devices (IPC)
• Graduated compression stockings (GCS)
• LDUH or LMWH or Factor Xa Inhibitor (fondaparinux) combined with IPC or GCS
Elective Total Hip Replacement
Any of the following started within 24 hours of surgery:
• Low molecular weight heparin (LMWH)
• Factor Xa Inhibitor (Fondaparinux)
• Warfarin
-Oral Factor Xa Inhibitor
Elective Total Knee Replacement
Any of the following:
• Low molecular weight heparin (LMWH)
• Factor Xa Inhibitor (Fondaparinux)
• Warfarin
• Intermittent pneumatic compression devices (IPC)
• Venous foot pump (VFP)
-Oral Factor Xa Inhibitor3
Hip Fracture Surgery
Any of the following:
• Low-dose unfractionated heparin (LDUH)
• Low molecular weight heparin (LMWH)
• Factor Xa Inhibitor (Fondaparinux)
• Warfarin
Elective Total Hip Replacement with a reason for not administering pharmacological prophylaxis
Any of the following:
• Intermittent pneumatic compression devices (IPC)
• Venous foot pump (VFP)
Hip Fracture Surgery with a reason for not administering pharmacological prophylaxis
Any of the following:
• Graduated Compression Stockings (GCS)
• Intermittent pneumatic compression devices (IPC)
• Venous foot pump (VFP)
-
1.15 Denominator
Denominator Statement: All selected surgery patients
-
Exclusions
Data Elements:
• Admission Date
• Anesthesia End Date
• Anesthesia End Time
• Anesthesia Start Date
• Anesthesia Start Time
• Birthdate
• Clinical Trial
• Discharge Date
• ICD-9-CM Principal Diagnosis Code
• ICD-9-CM Principal Procedure Code
• Perioperative Death
• Preadmission Oral Anticoagulation Therapy
• Reason for Not Administering VTE Prophylaxis
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Surgery Project 2015-2017Initial EndorsementLast UpdatedRemoval Date
-
Steward Organization Email
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)
-
Planned Use
-